Latest filing published 06 Jul 2026 for Evolent Health, Inc., €13k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jonathan Weinberg is a declared insider of Evolent Health, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 17 filings cover trades dated from 4 May 2021 to 1 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 July 2026 came the latest disclosure, a share grant in Evolent Health, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations